Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?

Dirican, Ahmet; Kucukzeybek, Betul; Alacacioglu, Ahmet; Kucukzeybek, Yuksel; Erten, Cigdem; Varol, Umut; Somali, Isil; Demir, LÜTFİYE; Bayoglu, Ibrahim; Yildiz, Yasar; Akyol, Murat; Koyuncu, Betul; Coban, Eyup; Ulger, Eda; Unay, Fulya; Tarhan, Mustafa

doi:10.1007/s10147-014-0672-8

Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?

Atıf İçin Kopyala

Dirican A., Kucukzeybek B. B., Alacacioglu A., Kucukzeybek Y., Erten C., Varol U., ...Daha Fazla

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, cilt.20, ss.70-81, 2015 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 20
Basım Tarihi: 2015
Doi Numarası: 10.1007/s10147-014-0672-8
Dergi Adı: INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.70-81
Eskişehir Osmangazi Üniversitesi Adresli: Hayır

Özet

Background The neutrophil-to-lymphocyte ratio (NLR) is a strong predictor of mortality in patients with cancer. Similarly, a study in a large series has shown that the newly defined derived NLR (dNLR; neutrophil/leukocyte-lymphocyte ratio) also has prognostic value. The present study retrospectively evaluates the prognostic significance of NLR and dNLR in breast cancer.